After the official ribbon cutting, customers and senior Berry personnel were honored in a traditional Pooja ceremony followed by the traditional lighting of a lamp. Guests then had the opportunity to tour the new building, which will create around 500 local jobs in the coming years and improve regional and global access to a wide range of advanced healthcare solutions.
“The opening of this impressive facility marks another major milestone in Berry’s worldwide healthcare operations,” commented Berry Global Chairman and CEO Tom Salmon.
“Our investment in a second factory in Bangalore further strengthens our ability to support healthcare companies with both regional expertise and global capabilities in the development of modern healthcare solutions. This will help to meet demand throughout Asia and beyond for patient-centric healthcare products, while at the same time creating new jobs that tap into the skills and knowledge of the local workforce.”
The 21,000sqm factory features some of the latest precision high quality manufacturing equipment, together with an ISO 8 class 10000 cleanroom, producing a wide variety of packaging products and medical devices for the ophthalmic, nasal, inhalation, dispensing, and self-injection industries.
Among the latest innovations that will be manufactured at the factory are the new Berry PneumoHaler breath actuated inhaler with dose indicator that helps to reduce asthma and COPD patient coordination errors and breathing variability; and the award-winning Activated Rispharm, a recyclable multidose antimicrobial dropper that is designed to help prevent eye microbial infections.
The Global Centre of Excellence will support the development of innovative solutions for both existing and new applications and markets, with the ability to respond quickly and effectively to new regulations and requirements. Central to much of the design work is to devise solutions that improve the patient experience in terms of usability, functionality, and medicine administration and adherence, while also taking into account the need for companies to meet ambitious sustainability goals.
With many of the world’s major pharma companies separating their operations into consumer health and pharmaceutical markets, a key focus for the Bangalore site will be to design patient-centric solutions for growing consumer health categories.
“This new facility ideally demonstrates Berry’s commitment to deliver its wide-ranging technical and design expertise on a local level, meeting the needs of customers of all sizes, from national and international businesses to local and start-up companies,” said Jean-Marc Galvez, President, Berry Global Consumer Packaging International.
“Specifically, we are ideally placed to support the forecasted growth for quality healthcare products in Asia, increasing their availability to many more people. We look forward to strengthening existing customer relationships and forging new partnerships in the introduction of innovative solutions that will benefit the lives of patient populations throughout the region.”